Home > National Drug Code (NDC) > PENICILLIUM NOTATUM CHRYSOGENUM

PENICILLIUM NOTATUM CHRYSOGENUM - 54575-214-02 - (penicillium chrysogenum var. chrysogenum)

Alphabetical Index


Drug Information of PENICILLIUM NOTATUM CHRYSOGENUM

Product NDC: 54575-214
Proprietary Name: PENICILLIUM NOTATUM CHRYSOGENUM
Non Proprietary Name: penicillium chrysogenum var. chrysogenum
Active Ingredient(s): 1    g/20mL & nbsp;   penicillium chrysogenum var. chrysogenum
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of PENICILLIUM NOTATUM CHRYSOGENUM

Product NDC: 54575-214
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA101376
Marketing Category: BLA
Start Marketing Date: 19671207

Package Information of PENICILLIUM NOTATUM CHRYSOGENUM

Package NDC: 54575-214-02
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (54575-214-02)

NDC Information of PENICILLIUM NOTATUM CHRYSOGENUM

NDC Code 54575-214-02
Proprietary Name PENICILLIUM NOTATUM CHRYSOGENUM
Package Description 2 mL in 1 VIAL, MULTI-DOSE (54575-214-02)
Product NDC 54575-214
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name penicillium chrysogenum var. chrysogenum
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19671207
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM
Strength Number 1
Strength Unit g/20mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of PENICILLIUM NOTATUM CHRYSOGENUM


General Information